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Background Tobacco use is the leading cause of preventable deaths in the world. By 
2030, more than 80% of these tobacco-related deaths will occur in low- and mid-
dle-income countries (LMICs). The aim of the Tobacco Control Capacity Programme 
(TCCP) therefore, is to reduce tobacco-related mortality and morbidity by building 
research capacity in LMICs.
Methods A consortium of fifteen partner organisations across eight countries (Ban-
gladesh, Ethiopia, Ghana, India, South Africa, the Gambia, Uganda and the UK) will 
offer extensive research methods and leadership training opportunities to conduct 
high quality research projects on policy and practice and establish strong research 
partnerships. An example of one such study using a mixed method design to inves-
tigate tobacco industry interference in Uganda is presented.
Results The TCCP programme will produce research that can inform policies and 
practice within countries to prevent or reduce tobacco use. By conducting research 
in three key areas (tobacco taxation, reducing illicit trade, and addressing tobacco 
industry interference, as well as other local priorities) the programme will help to 
reduce tobacco disease and death and also generate revenue for governments through 
taxation which aids other development priorities. While conducting research in 
LMICs on these themes TCCP will provide evidence to support better implementation 
of the Framework Convention for Tobacco Controls (FCTC), which will result in re-
ductions in tobacco-related mortality and morbidity and also help generate revenue 
for governments through taxation which aids other development priorities.
Conclusion The TCCP programme will create a cohort of skilled early-career re-
searchers and research leaders who will build cohesive and successful research teams 
in LMICs. It will also create several collaborative networks of researchers, policy-
makers and advocates to co-produce context-specific research on tobacco control 
and its translation into policy. This will advance implementation science in LMICs 
and improve population health. By generating context-specific evidence, the TCCP 
will support advocacy efforts to shift attitudes within communities and governments 
towards a stronger tobacco control. Policy makers will be assisted by the evidence 
generated in this programme to challenge aggressive tobacco industry tactics and 
implement effective tobacco control.
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Tobacco use causes more deaths globally than any other preventable risk factor, leading to 
approximately 7 million deaths each year (1). More than 6 million of these deaths are the re-
sult of tobacco use, with a further 890, 000 from non-smokers being exposed to second-hand 
smoke. Given current consumption patterns and trends, global tobacco-related deaths are 
expected to reach more than 8 million by 2030 (2); 80% of these deaths will be in low- and 
middle-income countries (LMICs) (3), with half occurring in working age adults, causing sig-
nificant loss to economic productivity (4). The current global deaths caused by tobacco ex-
ceeds those from HIV, tuberculosis and malaria combined (5).
Smoking causes a range of non-communicable diseases (NCDs), in addition to poor mater-
nal health and the health harms of second-hand smoke exposure. It is the only risk factor 
that is linked to the four common NCD groups (i.e. cardiovascular disease, cancer, chronic 
lung disease and diabetes) and is also the most prevalent – causing one in every six deaths 
from NCDs (6). It is estimated that the global costs of smoking are equivalent to 18% of what 
countries around the world spend on healthcare (7). Given that there is an approximate 30–
year lag at population level between the respective epidemics of tobacco use and mortality, 
the worst impact of the tobacco epidemic in years to come will be in LMICs. For this reason, 
policies to address tobacco use have been identified as ‘best-buy’ interventions for prevent-
ing NCDs in LMICs, many of which are already having near epidemics of NCDs in addition 
to having to fight against communicable diseases (8, 9).
Beyond this health focus, the huge social and economic impacts of tobacco production and 
use, and the potential to exacerbate inequalities within and between countries, are increas-
ingly recognised across several of the 17 Sustainable Development Goals (SDGs), as part of 
the United Nations 2030 Agenda for Sustainable Development. In 2012 it was estimated that 
tobacco use would deprive the global economy of about US$ 12.7 trillion over the following 
20 years, or about 1.3% of global GDP (10). More than 40% of the global economic cost of 
tobacco is currently borne by LMICs (11). Tobacco control can contribute to efforts to reduce 
inequality within and among countries, thereby advancing SDG10.
To address these challenges a global framework for action, the Framework Convention on To-
bacco Control (FCTC), was adopted by the World Health Assembly in 2003 under the auspic-
es of the World Health Organization (WHO), and to which 181 countries are now parties (12). 
The treaty seeks to reduce the burden of tobacco use through key supply and demand mea-
sures laid out in its articles. Key demand measures are in WHO’s ‘MPOWER’ report including 
“Monitoring tobacco use and prevention policies”, “Protecting people from tobacco smoke”, 
“Offering help to quit tobacco use”,” Warning about the dangers of tobacco”, “Enforcing bans 
on tobacco advertising, promotion, and sponsorship”, and ‘Raising taxes on tobacco” (13). 
Despite widespread ratification of the FCTC, many of its articles are not yet fully implement-
ed at the country level; where these have been ratified, enforcement is often poor. There is 
a significant and recognised ‘implementation gap’ in tobacco control which is exploited and 
exacerbated by the tobacco industry, who continue to work extensively to prevent or weak-
en policy development and to undermine its implementation (14).
One of the factors directly contributing to this implementation gap is the severe shortage of 
policy-relevant research for effective tobacco control measures in LMICs. The majority of to-
bacco control research happens in high income countries (HICs). This is not always transfer-
rable to LMIC settings on account of differences in the population; availability of a diverse 
range of tobacco products; socio-cultural determinants; related health, economic and envi-
ronmental risks; associated behaviours and co-morbidities; agricultural and market econo-
my influences; and political contexts. Even when evidence from studies in HICs should be 
transferrable, policymakers in LMICS may be reluctant to use or learn from these studies. To 
inform better policies and their implementation, research conducted in and between LMICs 
is needed, particularly that which involves engagement with policy makers from the outset. 
However, there is a dearth of researchers in these countries with the necessary substantive 
and methodological expertise who also have good links with relevant stakeholders (15). This 
is partly because the international development agenda has historically prioritised work on 
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communicable diseases. Despite the well documented and growing health harms caused by 
tobacco use in LMICs this agenda has not, until very recently, focussed on tobacco control 
research. Organizations such as the Bloomberg Philanthropies, Gates Foundation, Interna-
tional Development Research Centre, and the Fogarty International Centre have invested in 
tobacco control initiatives focused on promoting research, research capacity building and 
implementation of proven interventions in LMICs. There are also recent investments in in-
ternational tobacco control research by the Global Alliance for Chronic Diseases, Medical 
Research Council UK, Newton Fund, Cancer Research UK (CRUK) and the National Institute 
for Health Research, among others. Nevertheless, development assistance for tobacco control 
activities in LMICs remain inadequate considering the disease burden due to tobacco use in 
these countries (16).
This paper presents the aims, methods and theory guiding delivery of the Tobacco Control 
Capacity Programme (TCCP) funded by UK Research and Innovation (UKRI) as part of the 
Global Challenges Research Fund.
METHODS
Aim and objectives of TCCP
The overall aim of the TCCP is to increase research capacity in seven LMICs (Bangladesh, 
Ethiopia, Ghana, India, South Africa, the Gambia, Uganda) to create evidence to reduce the 
morbidity and mortality caused by tobacco use and to advance key development priorities.
The objectives of the TCCP are to:
1.  Develop a consortium of partners led by the UK Centre for Tobacco and Al-
cohol Studies, a UK Clinical Research Collaboration (UKCRC) Centre of Ex-
cellence involving 13 Universities.
2.  Establish and train a cohort of post-doctoral fellows in the participating LMIC 
and UK research organisations to generate evidence to support tobacco con-
trol implementation.
3.  Develop new research through a process of co-creation of research topics, 
data collection approaches and plans for dissemination between participat-
ing academics, government and Non-Governmental Organisations (NGOs) 
partners in each LMIC.
4.  Apply findings from these new studies to inform the implementation of ef-
fective tobacco control and development policy measures (reducing the de-
mand for, and supply of, tobacco products) in each participating country and 
internationally.
5.  Engage post-doctoral fellows, co-applicants and collaborators in existing 
and new training opportunities in relevant research methods, tobacco con-
trol research and advocacy skills that will be offered by UK and LMIC Uni-
versities and CRUK.
6.  Invest in wider stakeholder engagement (for example, Ministries of Health 
and Finance) to identify pathways to impact and future options for the sus-
tainability of the programme.
Study design
Delivery of the TCCP will be guided by Cooke’s framework for building research capacity 
that identifies six key elements: co-creation of research close to practice (objective 3); in-
frastructure (objective 2); skills and confidence-building (objective 5); linkages and collab-
orations (objectives 1 and 6); actionable dissemination (objective 4); and sustainability (ob-
jectives 6) (17).
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We have used a Theory of Change approach to map these elements in an outcome framework. 
For the TCCP, the Theory of Change is based on the premise that by strengthening the capac-
ity of LMIC research institutions and supporting the development of new country-specific 
research on tobacco control that more country relevant data will be available to support the 
implementation of effective tobacco control policies. This will only be realised if key stake-
holders, especially those with influence over policy design and decision making, are effec-
tively engaged throughout the programme.
To achieve this, the TCCP is being implemented by a consortium of fifteen research organ-
isations in eight countries: Bangladesh, Ethiopia, Ghana, India, South Africa, the Gambia, 
Uganda and the UK. The organisations in the consortium have a diverse range of skills, ex-
pertise and experience levels of working in tobacco control research. The TCCP will tailor its 
approach to capacity development and research to the skills and expertise of each individual 
partner, via four work packages.
Work Package One – building research capacity – will contribute to addressing lack of re-
search capacity in LMICs to undertake policy relevant research by funding 11 full-time ear-
ly career research fellow positions (eight with LMIC partner research institutions and three 
in the UK). Each research fellow will complete a skills assessment to create an individual 
training programme. As well as providing practical experience of designing and conducting 
research, the project will support and mentor research fellows to attend training to develop 
their topic-specific and methodological skills and expertise.
Country specific research projects is the focus of Work Package Two. Working groups, made 
up of collaborators from the UK and LMIC research institutions as well as additional experts 
where appropriate, will be established to develop research proposals. A peer review pro-
cess will be established to ensure quality and rigour across projects and map what is being 
achieved across the LMICs.
Development of country-specific projects will be guided by three research questions:
1.  To what extent do national approaches to tobacco taxation align with in-
ternational best practice, and how can these be enhanced to reduce tobacco 
consumption?
2.  How can local capacity to eliminate illicit trade in tobacco products be in-
creased, advancing implementation of the Protocol to the FCTC?
3.  What are the principal barriers experienced by governments in protecting 
public health policy from tobacco industry interference, with specific refer-
ence to taxation and illicit trade?
These questions centre on core tobacco control issues that directly engage with broader chal-
lenges in global health and development, constitute priorities in FCTC implementation, and 
respond to local needs identified by our research partners and by government officials.
Research in each of the countries will address at least two of the priority areas identified 
above. It is envisaged that most of the research conducted in the project will generate re-
search findings using quantitative and qualitative methods, and desk based approaches (eg, 
reviews of policies/ guidelines/ media stories, analysis of existing datasets).
Case study: Assessing implementation of WHO FCTC Article 5.3 and  
its guidelines in Uganda
Here we include a case study of one of the planned research projects in the TCCP. As noted 
earlier the FCTC has a number of Articles that provide guidance to governments on how to 
implement the FCTC. Article 5.3 is concerned with tobacco industry interference and sets out 
guiding principles and recommendations to protect public health polices from (and monitor 
the extent of) tobacco industry interference (12). However, implementation of Article 5.3 is 
poor, resulting in continued tobacco industry lobbying of governments which stalls, delays 
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or weakens tobacco control measures (1, 18). This aim of this study is to assess the extent of 
awareness and implementation of article 5.3 in Uganda. Ethical approval for the study has 
been secured from Universities in Uganda and the UK. The first stage of the study will be a 
desk-based review of published and unpublished literature including policy documents and 
parliamentary proceedings. Information related to awareness and any examples of imple-
mentation of Article 5.3 will be systematically extracted using a data extraction template 
and a thematic analysis conducted to summarise key findings. This will be augmented by 
semi-structured stakeholder interviews at the national level in Uganda (n=15), using purpo-
sive sampling, with policy makers, civil servants, advocates and non-government organisa-
tions. Interviews will be audio recorded, then transcribed verbatim and analysed using NVi-
vo 11 (QSR International Pty Ltd, Victoria, Australia). A coding frame will be developed and, 
once pilot tested, transcripts will be coded to facilitate thematic analysis. Findings from the 
document review and the semi structure interviews will be triangulated to provide a fuller 
picture of awareness and implementation of Article 5.3.
Work Package Three is concerned with stakeholder engagement that will support the design 
of policy relevant research and generate demand for the research outputs that will be pro-
duced within the project. Stakeholder engagement events will be hosted by each LMIC re-
search institution in years 1 and 4. These events will: provide a platform to discuss research 
projects; disseminate findings; highlight implications for policy; and identify future research 
priority areas. Investment in these activities will increase the likelihood of the project re-
search outputs influencing policy discussions and debates.
Finally, Work Package Four – building collaborations and monitoring impact – has two ob-
jectives. First, to strengthen collaboration within the consortium both within and beyond 
the current timeframe of the project. This will be achieved through the facilitation of regular 
contact between TCCP team members, and annual face to face team meetings. Secondly, to 
monitor the progress of the programme and assess how outputs and activities may contrib-
ute to informing policy, practice and future research.
Ethics and dissemination
Research in each of the countries will be submitted for research ethics approval in the UK 
and the relevant LMIC before studies commence. In addition to our stakeholder engage-
ment activities discussed under Work Package 3, we will collaborate across teams to produce 
peer-reviewed articles for international journals. The TCCP will also support UK and LMIC 
researchers to present at a range of relevant academic, practitioner and policy-relevant con-
ferences. We will develop a TCCP programme specific and country specific websites and pro-
vider regular project updates via social media.
DISCUSSION
The TCCP programme responds to some of the key challenges to effective tobacco control and 
reasons for inadequate implementation of the FCTC articles in LMICs. These include a severe 
shortage of: academic leaders skilled in the field of tobacco control; context-specific, timely 
and policy-relevant research; and networks of researchers, advocates and policy makers to 
provide stewardship at the national level. The TCCP programme will fill this gap by building 
capacity among research teams in LMICs in South Asia and Sub-Saharan Africa and in the 
UK to conduct applied research to inform policy and practice and to provide scientific support 
to address the tobacco epidemic. Research capacity and impact will be created and sustained 
beyond the TCCP in three ways: 1) establishing a strong, supported group of post-doctoral 
fellows in tobacco control research; 2) establishing institutional links with academic, gov-
ernmental and NGO partners, and; 3) seeking additional funding for future work, involving 
more countries to work across regions and NCDs.
By conducting research in LMICs on three key themes (tobacco taxation, reducing illicit trade, 
and addressing tobacco industry interference, as well as other local priorities) the programme 
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will provide data and specific examples that will help make the case for better implemen-
tation of the FCTC, resulting in reductions in tobacco disease and death and also helping to 
generate revenue for governments through taxation which aids other development priorities.
For early career researchers in LMIC, the TCCP programme offers a unique opportunity to 
develop themselves as research leaders in tobacco control. This includes a bespoke personal 
development programme in tobacco science and policy, mentorship, networking opportuni-
ties, and training in research and leadership. Furthermore, TCCP programme will create sev-
eral collaborative networks of researchers, policymakers and advocates to co-produce con-
text-specific research on tobacco control and its translation into policy. This will advance 
implementation science in LMICs and improve population health. The programme will develop 
capacity among LMIC researchers and advocates in applied research and in communicating 
research. By generating context-specific evidence, the TCCP will support advocacy efforts 
to shift attitudes within communities and governments towards a stronger tobacco control. 
Policy makers will be assisted by the evidence generated in this programme to challenge ag-
gressive tobacco industry tactics and implement effective tobacco control.
TCCP is an ambitious programme and is likely to face several challenges. The absence or lim-
ited capacity and consequential lack of support of national bodies to coordinate tobacco con-
trol priorities, develop policy and translate evidence into action is a potential challenge that 
may impact the long-term sustainability of the programme. For example, lack of provision 
for trained LMIC research fellows to use their skills to inform local tobacco control policy 
and practice could result in ‘brain drain’ to high income countries (19, 20). The TCCP aims 
to build stronger links between research, policy and practice through co-creation of knowl-
edge. Inadequate governance and research support structures (including limited regulatory 
and ethics review capacity and research administration and management), and material ca-
pacity (eg, peer reviewed journal availability) could also create environments that are not 
conducive to research. Nevertheless, the global research ethics landscape has expanded con-
siderably since 2000, with organizations such as the Fogarty International Center, Wellcome 
Trust, European Developing Countries Clinical Trials Partnership, World Health Organization, 
UNAIDS, African AIDS Vaccine Programme, Family Health International, US Department of 
Health and Human Services Office for Human Research Protections [OHRP], US NIH Depart-
ment of Bioethics investing in short and long-term research ethics board strengthening and 
training activities in LMICs (21). The TCCP offers a platform to identify where challenges 
exist and make recommendations for long-term, systems approaches capable of developing 
a critical self-sustaining mass of tobacco control research capacity in LMICs. It is also ex-
pected that the programme will be subject to pressure from the tobacco industry given their 
aim of further developing the markets in South Asia and Africa. At the time of writing, l 
two Freedom of Information requests have been received and responded to. While we do not 
know if these originate from tobacco industry actors, our previous experience with FOI re-
quests suggests they may (22).
At this early stage in the programme delivery we have identified three key messages that may 
be of interest for funders, policy makers and researchers. First, it is important that funders 
provide ongoing opportunities to support researchers and research teams in LMICs to sus-
tain and grow the research and networks that have been established within this and simi-
lar programmes. Second, policy makers charged with implementing the FCTC need to invest 
in, and be supported to build, relationships with other ministries to implement all aspects of 
the convention. Strong, collaborative links between authorities such as health and tax rev-
enue bodies is needed to strengthen implementation on a country by country basis. Third, 
researchers, policy makers and other key stakeholders (programme managers, revenue au-
thorities etc.) should be engaged throughout to design policy relevant research and create 
shared ownership, maximising potential for impact.
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